Anxo Pharmaceutical Co., Ltd. (6677) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Anxo Pharmaceutical Co., Ltd. (6677:TWSE), powered by AI.

Current Price
$16.85
Sector
Healthcare
What is the Anxo Pharmaceutical Co., Ltd. stock price forecast?

Anxo Pharmaceutical Co., Ltd. is currently trading at $16.85. View real-time AI analysis on Alpha Lenz.

What is Anxo Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Anxo Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Anxo Pharmaceutical Co., Ltd.'s P/E ratio?

View Anxo Pharmaceutical Co., Ltd.'s valuation metrics on Alpha Lenz.

Anxo Pharmaceutical Co., Ltd.

TWSE · 6677
NT$16.85-0.05(-0.30%)
Ask about Anxo Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Anxo Pharmaceutical Co., Ltd.'s ROE is -3.4%. Explore profitability and growth together.

Ask for details

Company Overview

Anxo Pharmaceutical Co., Ltd. is a specialty pharmaceutical company based in Taipei, Taiwan, established in 2003. The company develops, manufactures, and markets a diverse array of pharmaceutical products, catering to both medical professionals and patients domestically and internationally. Its product portfolio covers both prescription and over-the-counter medications, encompassing major therapeutic areas such as cardiovascular care, metabolic disorders, central nervous system diseases, diabetes, respiratory illnesses, anti-infective treatments, dermatology, nephrology, urology, and orthopedics. Anxo is recognized for offering a comprehensive range of pharmaceutical formulations, including oral drugs, injectables, and topical preparations, addressing a broad spectrum of therapeutic needs. The company also supports the pharmaceutical sector with analytical method development and validation services. As an active participant in Taiwan’s healthcare sector, Anxo Pharmaceutical plays a significant role in supplying essential medicines across various specialties, contributing to the accessibility and advancement of medical treatment options in the region.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$843.26MRevenue
0.00Shares Out
0Employees

Margins

35.60%Gross
5.70%EBITDA
-5.09%Operating
-5.41%Pre-Tax
-4.17%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-0.89%Rev 3Yr
-0.53%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-1.68%ROA
-3.39%ROE
-1.39%ROIC

Financial Health

NT$363.37MCash & Cash Equivalents
NT$595.33MNet Debt
86.52%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Anxo Pharmaceutical Co., Ltd. (ticker: 6677) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).

The current price is 16.85 with a P/E ratio of -x and P/B of -x.

ROE is -3.39% and operating margin is -5.09%. Annual revenue is $843M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Anxo Pharmaceutical Co., Ltd. (6677) Stock Forecast 2026 $16.85 — Price, Financials & Analyst Targets | Alpha Lenz